Ars Pharmaceuticals Inc (SPRY)

Cash & Short-Term Investments

$143.85M

Quarterly · Period ending: · USD

SPRY logo

SPRY Cash & Short-Term Investments

Latest reported$143.85M
SPRY Quarterly Cash & Short-Term Investments ($9.98M → $143.85M)
High-resolution chart · PNG

SPRY cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
143,845,000
200,969,000
244,986,000
288,209,000
240,130,000
275,727,000
314,022,000
204,624,000
218,744,000
223,632,000
228,360,000
241,902,000
252,208,000
264,548,999
274,381,000
37,322,000
44,590,000
253,847,000
60,063,000
300,660,000
359,689,000
374,205,000
386,569,000
9,976,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.